Butterfly Network announced today that it named Dr. Todd Fruchterman as its new president & CEO, effective Feb. 1. Fruchterman is set to take over for outgoing CEO Laurent Faracci, who stepped down this past weekend. Fruchterman assumes the role in advance of the closing of Butterfly Network’s announced merger with Longview Acquisition Corp., after […]
Mergers & Acquisitions
MedTech 100 roundup: Another peak for the industry
Medtech stocks have been on the rise in 2021, and the past week saw the trend continue with yet another all-time best mark. MassDevice‘s MedTech 100 index reached 107.4 points on Jan. 20, topping the all-time best of 106.81 points set on Jan. 8. That mark represents a 16% jump from the pre-pandemic high of 92.32 […]
The top 5 MassDevice stories of the week — January 22, 2021
It’s a new year with a new president who has new plans to fight the COVID-19 pandemic — a strategy that should be a big story for medtech in coming weeks. Even as President Biden and COVID-19 dominated the news, the medical device industry saw some important news in the hot robotic surgery space and […]
Boston Scientific to acquire Preventice Solutions
Boston Scientific (NYSE:BSX) announced today that it entered into a definitive agreement to acquire Preventice Solutions. Minneapolis-based Preventice designs mobile health solutions and remote monitoring services for patients with cardiac arrhythmias. Its wearables include the PatientCare platform and BodyGuardian family of monitors. Preventice’s BodyGuardian monitors use a fully-integrated, cloud-based platform for clinical technicians and AI algorithms […]
Obalon Therapeutics’ stock skyrockets after announcing ReShape Lifesciences merger
Shares of intragastric balloon maker Obalon Therapeutics (NSDQ:OBLN) jumped as high as $10.71 today, or 568%, after the company announced a merger with ReShape Lifesciences (OTCMKTS:RSLS). The San Diego-based company’s stock eventually closed at $9.52 per share, up 491%. Obalon’s stock had closed at $1.61 yesterday. ReShape Lifesciences also saw a substantial jump in its stock price. […]
Haemonetics to acquire Cardiva
Haemonetics (NYSE:HAE) announced today that it entered into a definitive agreement to acquire Cardiva Medical for $475 million. Boston-based Haemonetics’ agreement includes an upfront cash payment of $475 million at closing, along with up to an additional $35 million in contingent consideration based on sales growth, according to a news release. The acquisition is subject to […]
DJO acquires Trilliant Surgical and its foot and ankle implants
DJO announced that it acquired orthopedic foot and ankle implant maker Trilliant Surgical for an undisclosed amount. Dallas-based Colfax (NYSE:CFX) unit DJO’s acquisition is meant to support its focus on expansion into the high-growth U.S. foot and ankle market, which the company touts as a $1 billion market, according to a news release. Trilliant’s product portfolio […]
Protolabs to acquire 3D Hubs for up to $330M
Protolabs (NYSE: PRLB) today announced it plans to acquire Amsterdam-based 3D Hubs, an online manufacturing platform that provides engineers with on-demand access to a global network of approximately 240 manufacturing partners. The transaction creates a comprehensive digital manufacturing offer for custom parts, expanding Protolabs’ breadth of capabilities as well as adding a broader offering of pricing and lead-time […]
Hillrom to buy Bardy Diagnostics for $375M
Hillrom (NYSE:HRC) has agreed to spend $375 million to acquire Bardy Diagnostics and its Carnation Ambulatory Monitor, or CAM patch. Analysts at Baird described the CAM patch as a long-term Holter wearable biosensor. Hillrom said in a news release out today that the BardyDx purchase complements Hillrom’s present cardiology portfolio of cardiac stress exercise, Holter and […]
Philips acquires Capsule Technologies and its medical device data tech
Royal Philips (NYSE:PHG) announced today that it agreed to acquire Capsule Technologies in a deal worth $635 million. Andover, Mass.-based Capsule Technologies develops medical device integration and data technologies for hospitals and healthcare organizations. Its offerings include a medical device information platform for integration, vital signs monitoring and clinical surveillance services, according to a news release. […]
Thermo Fisher to acquire Mesa Biotech
Thermo Fisher Scientific (NYSE:TMO) today announced it will acquire Mesa Biotech, a privately held molecular diagnostic company, for approximately $450 million in cash. Under the terms of the agreement, Thermo Fisher will pay up to an additional $100 million in cash upon the completion of certain milestones following the close of the transaction. Mesa Biotech has […]
